All-seeing orbs, a distant planet and source of a life-giving drug, interstellar faster-than-light space travel, a carbon-freezing technique used to lock away enemies.
The science fiction and fantasy creations—carbonite, palantir, Arrakis, warp drive—evoke the sort of futuristic vision that many startups... Read more »
Earlier this month, GM CEO Mary Barra told the crowd at a financial conference that her company was on track to unveil a ridesharing service in 2019 that would be powered by autonomous vehicles. It sounded like pretty big news, but... Read more »
Salsify, a maker of e-commerce software, has acquired Welcome Commerce, an Austin-based developer of chat technology.
Boston-based Salsify sells technology that helps retail brands like Michelin and Anheuser-Busch manage their products across e-commerce platforms such as Amazon (NASDAQ: AMZN),... Read more »
Dallas — A foundation started by a Texas billionaire announced Tuesday it will offer millions of dollars in awards to scientists who research neurodegenerative diseases such as Alzheimer’s and progressive supranuclear palsy.
The Rainwater Charitable Foundation, which was founded in the... Read more »
Amazon is reportedly choosing two cities, not one, for its second headquarters, according to sources cited by The Wall Street Journal and The New York Times.
Amazon (NASDAQ: AMZN) is working on a deal to move into both the... Read more »
Esperanto Technologies, a startup AI chip developer that has operated mostly below the radar since its founding in 2014, announced this week that it raised $58 million in a Series B fundraising round.
Mountain View, CA-based Esperanto is vying with... Read more »
Broadcom is selling application security testing business Veracode for $950 million to private equity firm Thoma Bravo. Broadcom gained Veracode as a part of its blockbuster acquisition of CA Technologies.
Broadcom (NASDAQ: AVGO) announced in June it would acquire CA... Read more »
The second-most advanced investigational drug in MEI Pharma’s four-asset portfolio is drawing attention from overseas as a potential treatment for several leukemias and lymphomas.
Japanese life sciences company Kyowa Hakko Kirin has agreed to pay the San Diego company $10 million... Read more »
So, your long-scrappy tech startup cashed a nine-figure check from a gaggle of venture capital types.
Launch a hiring spree? Land a beachhead in Europe? Squirrel some away for a rainy day? Build all the features into your gizmo... Read more »